YLDW yields 1.61% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, YLDW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YLDW + JNJ for your $10,000?
YLDW is a multi-asset fund that invests primarily in income-producing securities across equities, bonds, hybrids, and other yield-oriented assets. The fund seeks monthly distributions and a lower volatility profile than traditional equity-only funds. YLDW uses a bottom-up, research-driven process, targeting companies with strong cash flow, improving fundamentals, and sustainable distributions. The fund generates returns from dividends, interest, option premiums, and potential capital appreciation. Additionally, the fund employs a covered call strategy on most of its equity holdings. This generates premiums that generate additional income, partial downside protection, and enhanced yield in flat markets, while capping upside in strongly rising markets. Investments include dividend-paying stocks, preferred shares, convertibles, corporate bonds, REITs, MLPs, and money market instruments, with up to 40% potentially invested in foreign securities or ADRs. Holdings also include derivatives.
Full YLDW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.